{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T21:42:25Z","timestamp":1758922945767},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,4,28]],"date-time":"2011-04-28T00:00:00Z","timestamp":1303948800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Women with a personal history of breast cancer have a high risk of developing an ipsi- or contralateral recurrence. We aimed to compare the growth rate of primary breast cancer and recurrences in women who had undergone prior breast magnetic resonance imaging (MRI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Three hundred and sixty-two women were diagnosed with breast cancer and had undergone breast MRI at the time of diagnosis in our institution (2005 - 2009). Among them, 37 had at least one prior breast MRI with the lesion being visible but not diagnosed as cancer. A linear regression of tumour volume measured on MRI scans and time data was performed using a generalized logistic model to calculate growth rates. The primary objective was to compare the tumour growth rate of patients with either primary breast cancer (no history of breast cancer) or ipsi- or contralateral recurrences of breast cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty women had no history of breast cancer and 17 patients were diagnosed as recurrences (7 and 10 were ipsi- and contralateral, respectively). The tumour growth rate was higher in contralateral recurrences than in ipsilateral recurrences (growth rate [10<jats:sup>-3<\/jats:sup> days<jats:sup>-1<\/jats:sup>] 3.56 vs 1.38, p &lt; .001) or primary cancer (3.56 vs 2.09, p = 0.01). Differences in tumour growth were not significant for other patient-, tumour- or treatment-related characteristics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These findings suggest that contralateral breast cancer presents accelerated growth compared to ipsilateral recurrences or primary breast events.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-11-155","type":"journal-article","created":{"date-parts":[[2011,4,28]],"date-time":"2011-04-28T18:22:45Z","timestamp":1304014965000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Growth of breast cancer recurrences assessed by consecutive MRI"],"prefix":"10.1186","volume":"11","author":[{"given":"Ingrid","family":"Millet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Bouic-Pages","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Hoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Azria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Taourel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,28]]},"reference":[{"key":"2663_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nrc1650","volume":"5","author":"JJ Kim","year":"2005","unstructured":"Kim JJ, Tannock IF: Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer. 2005, 5: 516-525. 10.1038\/nrc1650.","journal-title":"Nat Rev Cancer"},{"key":"2663_CR2","first-page":"1307","volume":"61","author":"L Norton","year":"1977","unstructured":"Norton L, Simon R: Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat Rep. 1977, 61: 1307-1317.","journal-title":"Cancer Treat Rep"},{"key":"2663_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S1470-2045(00)00019-X","volume":"1","author":"AJ Davis","year":"2000","unstructured":"Davis AJ, Tannock JF: Repopulation of tumour cells between cycles of chemotherapy: a neglected factor. Lancet Oncol. 2000, 1: 86-93. 10.1016\/S1470-2045(00)00019-X.","journal-title":"Lancet Oncol"},{"key":"2663_CR4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1177\/000313480907501024","volume":"75","author":"N Wasif","year":"2009","unstructured":"Wasif N, Garreau J, Terando A, Kirsch D, Mund DF, Giuliano AE: MRI versus ultrasonography and mammography for preoperative assessment of breast cancer. Am Surg. 2009, 75: 970-975.","journal-title":"Am Surg"},{"key":"2663_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.amjsurg.2009.07.012","volume":"198","author":"GM Grimsby","year":"2009","unstructured":"Grimsby GM, Gray R, Dueck A, Carpenter S, Stucky CC, Aspey H, Giurescu ME, Pockaj B: Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging?. Am J Surg. 2009, 198: 500-504. 10.1016\/j.amjsurg.2009.07.012.","journal-title":"Am J Surg"},{"key":"2663_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1148\/radiol.2442051620","volume":"244","author":"C Kuhl","year":"2007","unstructured":"Kuhl C: The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology. 2007, 244: 356-378. 10.1148\/radiol.2442051620.","journal-title":"Radiology"},{"key":"2663_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1148\/radiol.2443051661","volume":"244","author":"CK Kuhl","year":"2007","unstructured":"Kuhl CK: Current status of breast MR imaging. Part 2. Clinical applications. Radiology. 2007, 244: 672-691. 10.1148\/radiol.2443051661.","journal-title":"Radiology"},{"key":"2663_CR8","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.ejca.2007.06.007","volume":"43","author":"SJ Lord","year":"2007","unstructured":"Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, Griffiths A, Parker S, Houssami N: A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer. 2007, 43: 1905-1917. 10.1016\/j.ejca.2007.06.007.","journal-title":"Eur J Cancer"},{"key":"2663_CR9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2214\/ajr.183.4.1831149","volume":"183","author":"F Sardanelli","year":"2004","unstructured":"Sardanelli F, Giuseppetti GM, Panizza P, Bazzocchi M, Fausto A, Simonetti G, Lattanzio V, Del Maschio A: Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004, 183: 1149-1157.","journal-title":"AJR Am J Roentgenol"},{"key":"2663_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1148\/radiol.2522081032","volume":"252","author":"FJ Gilbert","year":"2009","unstructured":"Gilbert FJ, Warren RM, Kwan-Lim G, Thompson DJ, Eeles RA, Evans DG, Leach MO: Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features. Radiology. 2009, 252: 358-368. 10.1148\/radiol.2522081032.","journal-title":"Radiology"},{"key":"2663_CR11","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/1097-0142(19930315)71:6<2013::AID-CNCR2820710615>3.0.CO;2-V","volume":"71","author":"JA Spratt","year":"1993","unstructured":"Spratt JA, von Fournier D, Spratt JS, Weber EE: Decelerating growth and human breast cancer. Cancer. 1993, 71: 2013-2019. 10.1002\/1097-0142(19930315)71:6<2013::AID-CNCR2820710615>3.0.CO;2-V.","journal-title":"Cancer"},{"key":"2663_CR12","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1002\/1097-0142(19930315)71:6<2020::AID-CNCR2820710616>3.0.CO;2-#","volume":"71","author":"JA Spratt","year":"1993","unstructured":"Spratt JA, von Fournier D, Spratt JS, Weber EE: Mammographic assessment of human breast cancer growth and duration. Cancer. 1993, 71: 2020-2026. 10.1002\/1097-0142(19930315)71:6<2020::AID-CNCR2820710616>3.0.CO;2-#.","journal-title":"Cancer"},{"key":"2663_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/bjc.1998.503","volume":"78","author":"D Hart","year":"1998","unstructured":"Hart D, Shochat E, Agur Z: The growth law of primary breast cancer as inferred from mammography screening trials data. Br J Cancer. 1998, 78: 382-387. 10.1038\/bjc.1998.503.","journal-title":"Br J Cancer"},{"key":"2663_CR14","first-page":"7067","volume":"48","author":"L Norton","year":"1988","unstructured":"Norton L: A Gompertzian model of human breast cancer growth. Cancer Res. 1988, 48: 7067-7071.","journal-title":"Cancer Res"},{"key":"2663_CR15","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/bcr2092","volume":"10","author":"H Weedon-Fekjaer","year":"2008","unstructured":"Weedon-Fekjaer H, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S: Breast cancer tumor growth estimated through mammography screening data. Breast Cancer Res. 2008, 10: R41-10.1186\/bcr2092.","journal-title":"Breast Cancer Res"},{"key":"2663_CR16","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.ejca.2005.02.034","volume":"41","author":"MM Tilanus-Linthorst","year":"2005","unstructured":"Tilanus-Linthorst MM, Kriege M, Boetes C, Hop WC, Obdeijn IM, Oosterwijk JC, Peterse HL, Zonderland HM, Meijer S, Eggermont AM, et al: Hereditary breast cancer growth rates and its impact on screening policy. Eur J Cancer. 2005, 41: 1610-1617. 10.1016\/j.ejca.2005.02.034.","journal-title":"Eur J Cancer"},{"key":"2663_CR17","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.1158\/1078-0432.CCR-07-0689","volume":"13","author":"MM Tilanus-Linthorst","year":"2007","unstructured":"Tilanus-Linthorst MM, Obdeijn IM, Hop WC, Causer PA, Leach MO, Warner E, Pointon L, Hill K, Klijn JG, Warren RM, Gilbert FJ: BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials. Clin Cancer Res. 2007, 13: 7357-7362. 10.1158\/1078-0432.CCR-07-0689.","journal-title":"Clin Cancer Res"},{"key":"2663_CR18","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"M Clarke","year":"2005","unstructured":"Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005, 366: 2087-2106.","journal-title":"Lancet"},{"key":"2663_CR19","doi-asserted-by":"crossref","unstructured":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005, 365: 1687-1717.","DOI":"10.1016\/S0140-6736(05)66544-0"},{"key":"2663_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/(SICI)1520-6823(1999)7:6<321::AID-ROI2>3.0.CO;2-Q","volume":"7","author":"RK Schmidt-Ullrich","year":"1999","unstructured":"Schmidt-Ullrich RK, Contessa JN, Dent P, Mikkelsen RB, Valerie K, Reardon DB, Bowers G, Lin PS: Molecular mechanisms of radiation-induced accelerated repopulation. Radiat Oncol Investig. 1999, 7: 321-330. 10.1002\/(SICI)1520-6823(1999)7:6<321::AID-ROI2>3.0.CO;2-Q.","journal-title":"Radiat Oncol Investig"},{"key":"2663_CR21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJM199203193261201","volume":"326","author":"JD Boice","year":"1992","unstructured":"Boice JD, Harvey EB, Blettner M, Stovall M, Flannery JT: Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med. 1992, 326: 781-785. 10.1056\/NEJM199203193261201.","journal-title":"N Engl J Med"},{"key":"2663_CR22","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1200\/JCO.2007.16.0192","volume":"26","author":"MJ Hooning","year":"2008","unstructured":"Hooning MJ, Aleman BM, Hauptmann M, Baaijens MH, Klijn JG, Noyon R, Stovall M, van Leeuwen FE: Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. J Clin Oncol. 2008, 26: 5561-5568. 10.1200\/JCO.2007.16.0192.","journal-title":"J Clin Oncol"},{"key":"2663_CR23","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/jnci\/84.16.1245","volume":"84","author":"HH Storm","year":"1992","unstructured":"Storm HH, Andersson M, Boice JD, Blettner M, Stovall M, Mouridsen HT, Dombernowsky P, Rose C, Jacobsen A, Pedersen M: Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst. 1992, 84: 1245-1250. 10.1093\/jnci\/84.16.1245.","journal-title":"J Natl Cancer Inst"},{"key":"2663_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.radonc.2007.10.002","volume":"86","author":"BS Yadav","year":"2008","unstructured":"Yadav BS, Sharma SC, Patel FD, Ghoshal S, Kapoor RK: Second primary in the contralateral breast after treatment of breast cancer. Radiother Oncol. 2008, 86: 171-176. 10.1016\/j.radonc.2007.10.002.","journal-title":"Radiother Oncol"},{"key":"2663_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0360-3016(85)90179-8","volume":"11","author":"BA Fraass","year":"1985","unstructured":"Fraass BA, Roberson PL, Lichter AS: Dose to the contralateral breast due to primary breast irradiation. Int J Radiat Oncol Biol Phys. 1985, 11: 485-497. 10.1016\/0360-3016(85)90179-8.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2663_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/0360-3016(95)02051-9","volume":"34","author":"CA Kelly","year":"1996","unstructured":"Kelly CA, Wang XY, Chu JC, Hartsell WF: Dose to contralateral breast: a comparison of four primary breast irradiation techniques. Int J Radiat Oncol Biol Phys. 1996, 34: 727-732. 10.1016\/0360-3016(95)02051-9.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2663_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/0973-1482.31964","volume":"3","author":"A Chougule","year":"2007","unstructured":"Chougule A: Radiation dose to contralateral breast during treatment of breast malignancy by radiotherapy. J Cancer Res Ther. 2007, 3: 8-11. 10.4103\/0973-1482.31964.","journal-title":"J Cancer Res Ther"},{"key":"2663_CR28","first-page":"1254","volume":"60","author":"MH Barcellos-Hoff","year":"2000","unstructured":"Barcellos-Hoff MH, Ravani SA: Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 2000, 60: 1254-1260.","journal-title":"Cancer Res"},{"key":"2663_CR29","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","volume":"10","author":"SC Formenti","year":"2009","unstructured":"Formenti SC, Demaria S: Systemic effects of local radiotherapy. Lancet Oncol. 2009, 10: 718-726. 10.1016\/S1470-2045(09)70082-8.","journal-title":"Lancet Oncol"},{"key":"2663_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1470-2045(03)01196-3","volume":"4","author":"PW Szlosarek","year":"2003","unstructured":"Szlosarek PW, Balkwill FR: Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol. 2003, 4: 565-573. 10.1016\/S1470-2045(03)01196-3.","journal-title":"Lancet Oncol"},{"key":"2663_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S1470-2045(02)00900-2","volume":"3","author":"RR Weichselbaum","year":"2002","unstructured":"Weichselbaum RR, Kufe DW, Hellman S, Rasmussen HS, King CR, Fischer PH, Mauceri HJ: Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy. Lancet Oncol. 2002, 3: 665-671. 10.1016\/S1470-2045(02)00900-2.","journal-title":"Lancet Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-11-155\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:20:08Z","timestamp":1630614008000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-11-155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,28]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2663"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-11-155","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,28]]},"assertion":[{"value":"14 November 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"155"}}